These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19857742)

  • 1. Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignancies.
    Glowacki F; Al Morabiti M; Lionet A; Labalette M; Provot F; Noel C; Hazzan M
    Transplant Proc; 2009 Oct; 41(8):3323-5. PubMed ID: 19857742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subsets in renal transplant recipients with de novo genitourinary malignancies.
    Guichard G; Rebibou JM; Ducloux D; Simula-Faivre D; Tiberghien P; Chalopin JM; Bittard H; Saas P; Kleinclauss F
    Urol Int; 2008; 80(3):257-63. PubMed ID: 18480627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients.
    Esposito L; Kamar N; Tkaczuk J; Abbal M; Durand D; Rostaing L
    Transplant Proc; 2005 Mar; 37(2):785-7. PubMed ID: 15848531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic function, anti-thymocytes globulins, and cancer after renal transplantation.
    Ducloux D; Bamoulid J; Courivaud C; Gaugler B; Rebibou JM; Ferrand C; Chalopin JM; Borg C; Tiberghien P; Saas P
    Transpl Immunol; 2011 Jul; 25(1):56-60. PubMed ID: 21620972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATG induction therapy: long-term effects on Th1 but not on Th2 responses.
    Weimer R; Staak A; Süsal C; Streller S; Yildiz S; Pelzl S; Renner F; Dietrich H; Daniel V; Rainer L; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
    Transpl Int; 2005 Feb; 18(2):226-36. PubMed ID: 15691277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
    Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
    Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte subsets and assessment of cancer risk in renal transplant recipients.
    Ducloux D; Carron PL; Motte G; Ab A; Rebibou JM; Bresson-Vautrin C; Tiberghien P; Saint-Hillier Y; Chalopin JM
    Transpl Int; 2002 Sep; 15(8):393-6. PubMed ID: 12221457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of functionally distinct T-lymphocyte subsets in heart transplant recipients after induction therapy with anti-CD25 monoclonal antibodies.
    Lanio N; Sarmiento E; Gallego A; Navarro J; Palomo J; Fernandez-Yañez J; Ruiz M; Fernandez-Cruz E; Carbone J
    Transpl Immunol; 2013 Jun; 28(4):176-82. PubMed ID: 23611763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.
    Codarri L; Vallotton L; Ciuffreda D; Venetz JP; Garcia M; Hadaya K; Buhler L; Rotman S; Pascual M; Pantaleo G
    J Exp Med; 2007 Jul; 204(7):1533-41. PubMed ID: 17591854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy after kidney transplantation: results of 400 patients from a single center.
    Stratta P; Morellini V; Musetti C; Turello E; Palmieri D; Lazzarich E; Cena T; Magnani C
    Clin Transplant; 2008; 22(4):424-7. PubMed ID: 18312442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion.
    Klaus G; Mostert K; Reckzeh B; Mueller TF
    Transplantation; 2003 Dec; 76(12):1719-24. PubMed ID: 14688522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.
    Meignin V; Peffault de Latour R; Zuber J; Régnault A; Mounier N; Lemaître F; Dastot H; Itzykson R; Devergie A; Cumano A; Gluckman E; Janin A; Bandeira A; Socié G
    Exp Hematol; 2005 Aug; 33(8):894-900. PubMed ID: 16038781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary brain lymphomas after kidney transplantation: presentation and outcome.
    Snanoudj R; Durrbach A; Leblond V; Caillard S; Hurault De Ligny B; Noel C; Rondeau E; Moulin B; Mamzer-Bruneel MF; Lacroix C; Charpentier B
    Transplantation; 2003 Sep; 76(6):930-7. PubMed ID: 14508356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
    Korczak-Kowalska G; Wierzbicki P; Bocian K; Klosowska D; Niemczyk M; Wyzgal J; Korecka A; Durlik M; Chmura A; Paczek L; Górski A
    Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COX-2 gene promoter polymorphism -765 delays CD4 T-cell reconstitution after lymphocyte depletion with antithymocyte globulins.
    Courivaud C; Bamoulid J; Ferrand C; Tiberghien P; Chalopin JM; Saas P; Ducloux D
    Hum Immunol; 2011 Nov; 72(11):1060-3. PubMed ID: 21782872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.